Inventor · disambiguated record
David Leggett
Also filed as: LEGGETT DAVID
9 granted patents·7 pending applications·37 citations·filing 2008–2020
87Inventor score
Files withBOSTON BIOMEDICAL INC11LI CHIANG JIA2JIANG ZHIWEI1SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1SUMITOMO DAINNIPON PHARMA ONCOLOGY INC1
Top patents by PatentIndex Score
16 records- 0191US8877803B2Stat3 pathway inhibitors and cancer stem cell inhibitorsJIANG ZHIWEI·Filed 2008·Granted Nov 4, 2014·13 cites·3 claims
- 0286US9084766B2Compounds and compositions for targeting cancer stem cellsLI CHIANG JIA·Filed 2011·Granted Jul 21, 2015·7 cites·46 claims
- 0385US9381184B2Compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2015·Granted Jul 5, 2016·4 cites·37 claims
- 0484US9834532B2Stat3 pathway inhibitors and cancer stem cell inhibitorsBOSTON BIOMEDICAL INC·Filed 2014·Granted Dec 5, 2017·4 cites·6 claims
- 0580US10851075B2Stat3 pathway inhibitors and cancer stem cell inhibitorsSUMITOMO DAINIPPON PHARMA ONCOLOGY INC·Filed 2018·Granted Dec 1, 2020·1 cites·3 claims
- 0680US9730909B2Methods for targeting cancer stem cellsLI CHIANG JIA·Filed 2011·Granted Aug 15, 2017·4 cites·37 claims
- 0778US10017488B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2015·Granted Jul 10, 2018·2 cites·17 claims
- 0876US10683274B23-substituted carbonyl-naphtho[2,3-B]furane derivative or pharmaceutically acceptable salt thereofBOSTON BIOMEDICAL INC·Filed 2018·Granted Jun 16, 2020·1 cites·1 claims
- 0973US10543189B22-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancerBOSTON BIOMEDICAL INC·Filed 2019·Granted Jan 28, 2020·1 cites·15 claims
- 1064US2017197932A1Novel stat3 pathway inhibitors and cancer stem cell inhibitorsBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1158US2020397740A12-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancerSUMITOMO DAINNIPON PHARMA ONCOLOGY INC·Filed 2020·Application pending·0 cites
- 1258US2018193303A1Novel compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2018·Application pending·0 cites
- 1354US2016030384A12-acetylnaphtho[2,3-b]furan -4,9-dione for use on treating cancerBOSTON BIOMEDICAL INC·Filed 2014·Application pending·0 cites
- 1454US2016271099A1Novel compounds and compositions for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
- 1547US2017319537A1Novel methods for targeting cancer stem cellsBOSTON BIOMEDICAL INC·Filed 2017·Application pending·0 cites
- 1634US2018098959A1Methods for treating cancerBOSTON BIOMEDICAL INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David Leggett files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →